Marco Mastrodonato
Chief Executive Officer at BMG Pharma SpA
Profile
Marco Mastrodonato is the founder of BMG Pharma SpA, where he holds the title of Chief Executive Officer since 2011.
He previously worked at Sinclair Pharma Plc from 2001 to 2011, where he held the title of Executive Vice President.
Marco Mastrodonato active positions
Companies | Position | Start |
---|---|---|
BMG Pharma SpA
BMG Pharma SpA Household/Personal CareConsumer Non-Durables BMG Pharma SpA is a pharmaceutical company based in Milan, Italy. The Italian company specializes in the development and international partnership of bio-pharmaceutical products. The company focuses on the progress of oral care, dermatology, and dietary supplements. BMG Pharma is committed to sustainability, diversity, and inclusion in the workplace. BMG Pharma has developed the hyaluromimethic® technology, which they believe is a fundamental value. The company has registered 36 innovative products and launched 37 on the international market. Recently, BMG Pharma has signed an agreement with HTL Biotechnology for the production of the functional ingredient at the base of the patented hyaluromimethic®. The company was founded in 2011 by Marco Mastrodonato and Roberto Bianchi, with Marco Mastrodonato serving as the CEO since then. | Chief Executive Officer | 2010-12-31 |
Former positions of Marco Mastrodonato
Companies | Position | End |
---|---|---|
Sinclair Pharma Plc /Old/
Sinclair Pharma Plc /Old/ Pharmaceuticals: MajorHealth Technology Sinclair Pharma Plc is a specialty pharmaceutical company. It provides solutions to treat wounds, which include skin disinfection, radiation dermatitis treatment and wounds and burns healing; dermatology, which include fungal infections, acne, atopic dermatitis and family dermatology; as well as oral diseases, which include gingivitis, periodontitis, mouth ulcers and teething through advanced surface technology and innovative delivery systems. The company was founded by Andrew Sinclair in 1971 and is headquartered in Godalming, the United Kingdom. | Corporate Officer/Principal | 2011-06-26 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Sinclair Pharma Plc /Old/
Sinclair Pharma Plc /Old/ Pharmaceuticals: MajorHealth Technology Sinclair Pharma Plc is a specialty pharmaceutical company. It provides solutions to treat wounds, which include skin disinfection, radiation dermatitis treatment and wounds and burns healing; dermatology, which include fungal infections, acne, atopic dermatitis and family dermatology; as well as oral diseases, which include gingivitis, periodontitis, mouth ulcers and teething through advanced surface technology and innovative delivery systems. The company was founded by Andrew Sinclair in 1971 and is headquartered in Godalming, the United Kingdom. | Health Technology |
BMG Pharma SpA
BMG Pharma SpA Household/Personal CareConsumer Non-Durables BMG Pharma SpA is a pharmaceutical company based in Milan, Italy. The Italian company specializes in the development and international partnership of bio-pharmaceutical products. The company focuses on the progress of oral care, dermatology, and dietary supplements. BMG Pharma is committed to sustainability, diversity, and inclusion in the workplace. BMG Pharma has developed the hyaluromimethic® technology, which they believe is a fundamental value. The company has registered 36 innovative products and launched 37 on the international market. Recently, BMG Pharma has signed an agreement with HTL Biotechnology for the production of the functional ingredient at the base of the patented hyaluromimethic®. The company was founded in 2011 by Marco Mastrodonato and Roberto Bianchi, with Marco Mastrodonato serving as the CEO since then. | Consumer Non-Durables |
- Stock Market
- Insiders
- Marco Mastrodonato